Laddar...
Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers
BACKGROUND: Tenapanor, a small molecule with minimal systemic availability, is a first-in-class sodium/hydrogen exchanger 3 (NHE3) inhibitor that acts in the gut. Here, we evaluate the pharmacodynamics and safety of tenapanor in healthy adults. METHODS: Two phase I, single-center, randomized, double...
Sparad:
| I publikationen: | Clin Drug Investig |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856883/ https://ncbi.nlm.nih.gov/pubmed/29363027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-017-0614-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|